NCT05236543View on ClinicalTrials.gov

A Study to Assess the Pharmacokinetics of AZD4831 When Administered Alone and in Combination With Itraconazole

PHASE1CompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

February 18, 2022

Primary Completion Date

August 12, 2022

Study Completion Date

August 12, 2022

Conditions

Healthy Volunteers

Interventions

DRUG

AZD4831

Subjects will receive single oral dose only on Day 1 and Day 11.

DRUG

Itraconazole

Subjects will receive Itraconazole orally on Days 8 followed by dosing from Day 9 to Day 17.

Trial Locations (1)

HA1 3UJ

Research Site, Harrow

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Parexel

INDUSTRY

lead

AstraZeneca

INDUSTRY